Journal of Pharmacology and Experimental Therapeutics · 2014 · 132 citations · 37 references
PharmacyPharmacokineticsPharmacologyDrug DesignDrug DiscoveryProtein EngineeringBiologics DiscoveryLigand BindingProtein BindingProtein DesignProtein-ligand BindingTherapeutic Protein EngineeringAntibodiesFibronectin Type Iii DomainsLdl Cholesterol LoweringLow-density Lipoprotein Cholesterol LoweringLow-density Lipoprotein ParticlesPcsk9 Gain-of-function MutationsProprotein Convertase Subtilisin/kexin Type 9 InhibitionX-ray Structure Determination
37
<i>Phaser</i>crystallographic software
Airlie J. McCoy, Ralf W. Grosse‐Kunstleve, Paul D. Adams et al. · Journal of Applied Crystallography · 2007 · 20.9K citations · Full text
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
Marianne Abifadel, Mathilde Varret, Jean‐Pierre Rabès et al. · Nature Genetics · 2003 · 3K citations